Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arkadiusz Krysiński
Observed names:
A. Krysiński,
Arkadiusz Krysinski
Institutions:
Mossakowski Medical Research Institute, Polish Academy of Sciences,
National Medical Institute of the Ministry of Interior and Administration,
Polish Academy of Sciences
Observed institutions:
Central Clinical Hospital,
Mossakowski Medical Research Institute, Polish Academy of Sciences,
National Medical Institute of the Ministry of Interior and Administration,
Polish Academy of Sciences
ORCID:
0000-0002-4561-9574
Observed ORCID:
0000-0002-4561-9574
OpenAlex ID:
A5012884415
Influence of quitting smoking on diabetes-related complications: A scoping review with a systematic search strategy
2024
·
Magdalena Walicka
, Arkadiusz Krysiński
, et al.
·
Diabetes & Metabolic Syndrome Clinical Research & Reviews
·
33
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial
2022
·
Cristina Russo
, Magdalena Walicka
, et al.
·
JAMA Network Open
·
29
PDF
International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol
2021
·
Arkadiusz Krysiński
, Cristina Russo
, et al.
·
BMJ Open
·
10
PDF
A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study protocol
2023
·
Arkadiusz Krysiński
, Cristina Russo
, et al.
·
Internal and Emergency Medicine
·
9
PDF
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol
2021
·
C. Russo
, P. Caponnetto
, et al.
·
Internal and Emergency Medicine
·
4
PDF
Show more works
View as search
Works count:
5
Citation count:
85
H-index:
4
I10-index:
3
Year
Topic
Type